Method of administration of IGF-I
US5565428A · kind A · utility
Assignees
Inventors
Key dates
| Filing date | May 22, 1995 |
| Grant date | Oct 15, 1996 |
| Priority date | — |
| Expiry date | May 22, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method is disclosed that comprises administering insulin-like growth factor-I (IGF-I) to a mammal so as to sustain its biological activity in the mammal comprising administering a therapeutically effective amount of IGF-I to the mammal to provide an exposure to IGF-I for a period of time that stimulates the maximum biological response in the mammal, then discontinuing said administration for a period of time equal to or less than the time period used for administration, and repeating this pattern of administration and discontinuance of administration for a period as long as necessary to achieve or maintain the desired biological response in the mammal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.